Eagle Pharmaceuticals appoints Christopher Krawtschuk as CFO
The Fly

Eagle Pharmaceuticals appoints Christopher Krawtschuk as CFO

Eagle Pharmaceuticals (EGRX) announced the appointment of Christopher Krawtschuk as CFO of the Company, effective November 11, 2024. In connection with Mr. Krawtschuk’s appointment, Steven Ratoff stepped down from his role as interim CFO and will remain as a director on the Company’s board of directors. Most recently, Mr. Krawtschuk served as CFO and Treasurer of bluebird bio.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App